Meningococcal Disease
📧 Sign up to get email alerts when something new happens for Meningococcal Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-09-22Clinical Trial Update: Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan [Phase 3]
Phase 3 trial assessing the immunogenicity and safety of a meningococcal ACWY conjugate vaccine in healthy 2- to 18-year-olds in Taiwan; res…
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: Kinetics of B Cell Response in Infants Menjugate Vaccination [Phase 4]
A Phase 4 study reports on the kinetics of B cell response in infants receiving the Menjugate meningococcal conjugate vaccine for prevention…
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: Persistence of Immune Response After Vaccination With MCC [Phase 4]
Phase 4 trial evaluating durability of the immune response after MCC vaccination for prevention of meningococcal infection; the study has co…
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 Patients Vaccinated With MenBVac® (Extension MenbVac) [Phase 3]
A Phase 3 extension study of MenBVac evaluating immune response to Neisseria meningitidis serogroup B has completed, involving 16 vaccinated…
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 in Patients Having to be Vaccinated MenBVac® (Extension EFFIVAC)
A completed clinical trial update evaluating the immune response to a Neisseria meningitidis B strain in participants vaccinated with MenBVa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Persistence of Immunogenicity of MenACWY Conjugate Vaccine 5 Years After Childhood Vaccination, and Immune Response to a Booster Dose [Phase 4]
Phase 4 trial assessing how long the MenACWY meningococcal conjugate vaccine remains immunogenic five years after vaccination and the immune…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants [Phase 2]
Phase 2 clinical trial update assessing B cell response to a primary and booster course of the Novartis meningococcal ACWY conjugate vaccine…
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants [Phase 2]
A Phase 2 study evaluating GSK2197870A vaccine given as a primary course in infants has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years [Phase 3]
A Phase 3 trial evaluated the immunogenicity and safety of concomitant administration of a Tdap vaccine with a meningococcal ACWY conjugate …
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Infants [Phase 2]
A Phase 2 clinical trial assessing the safety and immune response of a meningococcal vaccine in healthy infants, with results posted in 2014…
-
CLINICAL_TRIALS trial_result · 2014-05-29Clinical Trial Update: The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Adolescents/Adults [Phase 2]
Phase 2 trial update reports long-term antibody persistence for GSK134612 meningococcal vaccine in healthy adolescents and adults.
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: Study of Sanofi Pasteur and Lanzhou Institute's Meningococcal (Group A and C) Polysaccharide Vaccine in Children [Phase 4]
Phase 4 clinical trial update of the Meningococcal Group A and Group C polysaccharide vaccine co-developed by Sanofi Pasteur and the Lanzhou…
-
CLINICAL_TRIALS trial_result · 2014-05-06Clinical Trial Update: Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of Booster Doses of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received One or Four Doses of the Same Vaccine [Phase 2]
Phase 2 extension study assessing antibody persistence, safety, tolerability, and immunogenicity of booster doses of Novartis rMenB±OMV NZ v…
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months [Phase 3]
A Phase 3 study evaluating the safety and immunogenicity of four doses of the MenACWY conjugate vaccine given with routine vaccines in 2-mon…
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Evaluating the Comparative Safety and Immunogenicity of Three Lots of Novartis Meningococcal C Conjugate Vaccine in Healthy Toddlers [Phase 2]
Phase 2 trial results evaluating safety and immunogenicity of three lots of Novartis Meningococcal C Conjugate Vaccine in healthy toddlers.
-
CLINICAL_TRIALS trial_result · 2014-03-24Clinical Trial Update: A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants [Phase 3]
A Phase 3 trial evaluating the safety and immune response of Novartis' meningococcal ACWY vaccine in infants has completed, with results pos…
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Children, Adolescents and Adults in Russia [Phase 3]
Phase 3 trial update assessing immunogenicity and safety of meningococcal ACWY conjugate vaccine in diverse age groups in Russia.
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of a Booster Dose of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received Three Doses of the Same Vaccine [Phase 2]
Extension Phase 2 study evaluating antibody persistence, safety, tolerability, and immunogenicity of a booster dose of Novartis rMenB±OMV NZ…
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults [Phase 3]
Phase 3b, randomized, open-label trial completed to evaluate safety and immunogenicity of select travel vaccines administered concurrently w…
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: Assessment of Antibody Persistence at Eighteen Months After the Completion of the Vaccination Course in Study V72P10 [Phase 2, Phase 3]
Phase 2/3 clinical trial update assessing antibody persistence 18 months after vaccination with the V72P10 candidate meningococcal vaccine.
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine [Phase 3]
A Phase 3 study evaluating the safety and immune response of a combined Hepatitis A/B vaccine with the MenACWY-CRM meningococcal conjugate v…
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: Safety and Immunogenicity Study for Use of Menactra® Versus Adacel® in Subjects 11 to 55 Years of Age in South Korea [Phase 3]
Phase 3 safety and immunogenicity trial comparing Menactra to Adacel in individuals aged 11 to 55 in South Korea has completed, with results…
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Study of the Safety and Immune Response of a Meningococcal Conjugate Vaccine Administered to Healthy Adolescents [Phase 2]
Phase 2 clinical trial evaluating the safety and immune response of a meningococcal conjugate vaccine in healthy adolescents. Results have b…
-
CLINICAL_TRIALS trial_result · 2013-11-05Clinical Trial Update: Safety and Immunogenicity of Meningococcal ACWY Conjugate Versus Polysaccharide Vaccine in Children 2 to 10 Years of Age [Phase 3]
Phase 3 trial comparing meningococcal ACWY conjugate vaccine to polysaccharide vaccine in children aged 2-10 assessing safety and immunogeni…
-
CLINICAL_TRIALS trial_result · 2013-10-18Clinical Trial Update: Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine or Meningococcal C Conjugate Vaccine [Phase 3]
Phase 3 trial update reporting on the persistence of antibody responses in children previously vaccinated with Novartis MenACWY Conjugate Va…